文献速递皮肤肿瘤

自体皮肤细胞悬液移植治疗稳定期白癜风:随机对照试验

Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation.
PubMed 文献 · J Am Acad Dermatol · 2024-09-07

美国多中心随机自身对照试验评估自体皮肤细胞悬液(ASCS)治疗成人稳定期白癜风的安全性和有效性,比较ASCS联合窄谱中波紫外线(NB-UVB)与单用NB-UVB。25例受试者中,ASCS治疗病灶24周≥80%复色比例36%,对照0%(P<.025),疗效持续至52周。

要点

  • ASCS联合NB-UVB较单用NB-UVB显著提高稳定期白癜风24周复色率。
  • ASCS安全性可接受,患者和研究者报告结局良好。
  • 样本量限制亚组分析,需更大研究验证。

核心结论

  • ASCS移植对稳定期白癜风病灶复色有潜在疗效,可能改善健康相关生活质量并减轻疾病负担。

研究设计与样本

  • 美国多中心、随机、自身对照试验,比较ASCS与单用NB-UVB在相似白癜风病灶中的效果,共25例受试者。

主要发现

  • ASCS治疗病灶24周≥80%复色比例为36%,对照为0%(P<.025)。
  • 复色疗效持续至52周。
  • ASCS安全性可接受,患者和研究者报告结局良好。

关键数值与推荐

  • 主要疗效终点为24周时达到≥80%复色的病灶比例。
  • ASCS在激光皮肤磨削后应用,随后接受NB-UVB治疗。

临床怎么用

  • ASCS可作为稳定期白癜风复色的一种治疗选择,需配合激光磨削和NB-UVB。

局限性

  • 研究样本量有限,限制稳健的亚组分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitiligo lesions are often challenging to repigment with conventional medical therapies. Surgical autologous melanocyte transfer methods can be utilized for stable vitiligo but demand specialized skills and equipment. A point-of-care autologous cell harvesting device was designed enabling simple preparation of autologous skin cell suspension (ASCS) containing melanocytes, keratinocytes, and fibroblasts providing a straightforward approach for cellular transplantation. OBJECTIVE: To evaluate the safety and effectiveness of ASCS for repigmentation of stable vitiligo lesions among adults. METHODS: A US multicenter, randomized, within-subject controlled trial compared ASCS to narrow band ultraviolet B only (Control) in similar vitiligo lesions. ASCS was applied after laser skin resurfacing and followed by narrow band ultraviolet B treatment. The primary effectiveness endpoint was the proportion of lesions achieving ≥80% repigmentation at week-24. Repigmentation durability was assessed at week-52. RESULTS: Among 25 subjects, 36% of ASCS-treated lesions achieved ≥80% repigmentation at week-24 compared to 0% for Control (P < .025), with durability through week-52. The safety profile of ASCS was acceptable, with favorable patient- and investigator-reported outcomes. LIMITATIONS: Study sample size limited robust subgroup analyses. CONCLUSION: Application of ASCS has potential as a treatment for repigmentation of stable vitiligo lesions with the potential to improve health-related quality of life and reduce burden of disease.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Hamzavi IH, Ganesan AK, Mahmoud BH, et al. Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation. J Am Acad Dermatol. 2024. PMID: 39182674. doi:10.1016/j.jaad.2024.08.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。